The Claim
Oral melatonin supplementation reduces fatigue, improves appetite, and enhances nutritional status while decreasing symptom burden in patients with heart failure-related cardiac cachexia, potentially counteracting the wasting syndrome associated with advanced heart failure.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking melatonin pills might help heart failure patients who are losing weight and feeling exhausted by boosting their appetite, cutting down their tiredness, and improving their overall nutrition.
See the scientific wording
Oral melatonin supplementation reduces fatigue and improves appetite in patients with heart failure-related cardiac cachexia, leading to better nutritional status and reduced symptom burden. These improvements in physical symptoms and nutritional markers suggest melatonin may help counteract the wasting syndrome commonly associated with advanced heart failure.
What the research says
1 studyData from one randomized controlled trial focusing on patients with heart failure-related cardiac cachexia assessed multiple symptom domains. The melatonin group demonstrated statistically significant improvements in fatigue scores (p=0.002), appetite ratings (p=0.004), and nutritional risk indices (p=0.015) compared to placebo. These concurrent improvements in physical symptoms and nutritional markers suggest that melatonin supplementation effectively counteracts the wasting syndrome and symptom burden characteristic of advanced cardiac disease.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.